Cargando…

Intravenous pulse methylprednisolone for the treatment of severe COVID-19

Detalles Bibliográficos
Autores principales:	Patoulias, Dimitrios, Dimosiari, Athina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Federation of Internal Medicine. Published by Elsevier B.V. 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9935278/ https://www.ncbi.nlm.nih.gov/pubmed/36822893 http://dx.doi.org/10.1016/j.ejim.2023.02.008

Ejemplares similares

Effect of COVID-19 on endothelial function evaluated with flow-mediated dilation: another prognostic marker? A meta-analysis of observational studies
por: Dimosiari, Athina, et al.
Publicado: (2022)

Therapeutic versus prophylactic heparin for thromboprophylaxis in patients with COVID-19: weighing the costs and benefits. A rapid meta-analysis of randomized controlled trials
por: Dimosiari, Athina, et al.
Publicado: (2022)

Anakinra or tocilizumab for prevention of COVID-19 death? A big dilemma
por: Patoulias, Dimitrios, et al.
Publicado: (2021)

Anti-Interleukins for Severe Coronavirus Disease-2019: Hype or Hope?
por: Dimosiari, Athina, et al.
Publicado: (2022)

Safety and efficacy of interleukin-1 antagonists in hospitalized patients with COVID-19
por: Dimosiari, Athina, et al.
Publicado: (2023)

Takayasu Arteritis is Associated with Impaired Arterial Stiffness: A Meta-Analysis of Observational Studies
por: Patoulias, Dimitrios, et al.
Publicado: (2022)

Do Interleukin-1 and Interleukin-6 Antagonists Hold Any Place in the Treatment of Atherosclerotic Cardiovascular Disease and Related Co-Morbidities? An Overview of Available Clinical Evidence
por: Dimosiari, Athina, et al.
Publicado: (2023)

How Should Concurrent Arterial and Venous Thrombosis Associated With SARS-CoV-2 Infection Be Managed?
por: Dimosiari, Athina, et al.
Publicado: (2022)

Meta-analysis addressing the impact of sodium-glucose Co-transporter-2 inhibitors on the risk for atrial fibrillation among individuals with heart failure with preserved ejection fraction
por: Patoulias, Dimitrios, et al.
Publicado: (2022)

Methylprednisolone pulse therapy: An alternative management of severe COVID-19
por: Sauñe, Patricia Merab, et al.
Publicado: (2020)

Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial
por: Edalatifard, Maryam, et al.
Publicado: (2020)

Early Stage Combination Treatment with Methylprednisolone Pulse and Remdesivir for Severe COVID-19 Pneumonia
por: Mastruzzo, Claudio, et al.
Publicado: (2023)

Effect of Glucagon-like Peptide-1 Receptor Agonists on Cardio-Metabolic Risk Factors among Obese/Overweight Individuals Treated with Antipsychotic Drug Classes: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Patoulias, Dimitrios, et al.
Publicado: (2023)

Intravenous methylprednisolone pulses in hospitalised patients with severe COVID-19 pneumonia: a double-blind, randomised, placebo-controlled trial
por: Salvarani, Carlo, et al.
Publicado: (2022)

Is the treatment with pulses of methylprednisolone safe?
por: Bednarczuk, Tomasz, et al.
Publicado: (2013)

A case of effective intravenous methylprednisolone pulse therapy against severe COVID‐19 infection after arteriovenous graft surgery
por: Kamata, Sokichi, et al.
Publicado: (2021)

Therapy of moderate-to-severe Graves’ orbitopathy with intravenous methylprednisolone pulses is not associated with loss of bone mineral density
por: Rymuza, Joanna, et al.
Publicado: (2018)

Intravenous pulse methylprednisolone for induction of remission in severe ANCA associated Vasculitis: a multi-center retrospective cohort study
por: Chanouzas, Dimitrios, et al.
Publicado: (2019)

Severe Adult Still's Disease Complicated by Purtscher-Like Retinopathy Treated with Intravenous Pulse Methylprednisolone and Tocilizumab
por: Akiyama, Kaho, et al.
Publicado: (2021)

Recurrence of optic nerve neuropathy - a possible side effect of intravenous methylprednisolone pulses treatment
por: Trautsolt, Katarzyna, et al.
Publicado: (2013)

Liver Dysfunction Associated with Intravenous Methylprednisolone Pulse Therapy in Patients with Graves' Orbitopathy
por: Eguchi, Hiroyuki, et al.
Publicado: (2015)

Safety of Intravenous Methylprednisolone in Refractory and Severe Pediatric Uveitis
por: Ghoraba, Hashem H, et al.
Publicado: (2022)

Intravenous methylprednisolone pulse therapy and the risk of in-hospital mortality among acute COVID-19 patients: Nationwide clinical cohort study
por: Moromizato, Takuhiro, et al.
Publicado: (2023)

Blood Pressure Profile and N-Terminal-proBNP Dynamics in Response to Intravenous Methylprednisolone Pulse Therapy of Severe Graves’ Orbitopathy
por: Miskiewicz, Piotr, et al.
Publicado: (2018)

Identification of patients with COVID-19 who are optimal for methylprednisolone pulse therapy
por: Ro, Shosei, et al.
Publicado: (2021)

Methylprednisolone pulse therapy and intravenous cyclophosphamide therapy combined with cocktail therapy in severe pediatric Henoch-Schönlein purpura nephritis patient
por: Kanai, Hiroaki, et al.
Publicado: (2013)

1125. Effect of intravenous pulses of methylprednisolone 250 mg versus dexamethasone 6 mg in hospitalized adults with severe COVID-19 pneumonia: an open-label randomized trial.
por: Gutierrez, Carlos Dueñas, et al.
Publicado: (2022)

Short and long-term effects of high-dose intravenous methylprednisolone pulse therapy on thyroid-associated ophthalmopathy
por: Liu, Xiaomei, et al.
Publicado: (2016)

Decrease in Bone Formation and Bone Resorption during Intravenous Methylprednisolone Pulse Therapy in Patients with Graves’ Orbitopathy
por: Rymuza, Joanna, et al.
Publicado: (2022)

High Dose Intravenous Methylprednisolone in the Treatment of Severe Acute Respiratory Syndrome: A Case Repor
por: Mishra, Sharmistha, et al.
Publicado: (2003)

High-dose methylprednisolone pulse therapy for the treatment of patients with severe COVID-19: Results from a prospective observational study
por: Bui, Thinh N., et al.
Publicado: (2022)

Pulse dexamethasone therapy versus pulse methylprednisolone therapy for treatment of Graves's ophthalmopathy
por: Philip, Rajeev, et al.
Publicado: (2013)

Report of a combination of remdesivir, intravenous methylprednisolone pulse, and tocilizumab for severe coronavirus disease: 20-case series at a single institution
por: Ichiyama, Takashi, et al.
Publicado: (2022)

Pulse Methylprednisolone Versus Dexamethasone in COVID-19: A Multicenter Cohort Study
por: Watanabe, Atsuyuki, et al.
Publicado: (2023)

High-dose intravenous methylprednisolone for the prophylactic treatment of cluster headache
por: Kawada, Sanami, et al.
Publicado: (2013)

Successful use of methylprednisolone for treating severe COVID-19
por: Liu, Jing, et al.
Publicado: (2020)

Intravenous methylprednisolone with or without tocilizumab in patients with severe COVID-19 pneumonia requiring oxygen support: A prospective comparison
por: Hamed, Dujana Mostafa, et al.
Publicado: (2021)

Comparing efficacy and safety of tocilizumab and methylprednisolone in the treatment of patients with severe COVID-19
por: Abbasian, Ladan, et al.
Publicado: (2022)

Methylprednisolone pulse therapy for critically ill patients with COVID-19: a cohort study
por: Choi, Keum-Ju, et al.
Publicado: (2023)

Comparison of the effect of intravenous dexamethasone and methylprednisolone on the treatment of hospitalized patients with COVID-19: a randomized clinical trial()
por: Dastenae, Zahra Habibi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_agl0d9fqecsjd2b97m7cr57mom